In this study, the association between ADH1B/ALDH2 gene polymorphism and serum metabolic factors, body statures, and hepatic steatosis/fibrosis status was evaluated in patients with NAFLD. The gene discussed is ALDH2; the disease is metabolic dysfunction-associated steatotic liver disease.